Rare Neurodegenerative Disease Efforts Under the ACT for ALS

Поделиться
HTML-код
  • Опубликовано: 6 окт 2024
  • In this webinar from Critical Path Institute's Rare and Orphan Disease Programs, we discuss in-depth the how the ACT for ALS will affect those living with the disease.
    To learn more visit: c-path.org/cp-rnd
    #cpath #fda #collaboration #als #neuroscience #neurodenerativediseases

Комментарии •